Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Biomed Pharmacother ; 159: 114253, 2023 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-36680813

RESUMO

RATIONALE: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) has a poor prognosis and high mortality. However, there is limited information regarding the mechanisms of AE-IPF. AIMS: We aimed to explore the function of macrophage-inducible C-type lectin (Mincle) in AE-IPF. METHODS: In the present study, Mincle was detected in the lung tissues of AE-IPF patients. Mincle-deficient (Mincle-/-) mice and wild-type C57BL/6 mice were administered bleomycin (BLM), followed by HSV1 viral infection to establish the AE-IPF model. RESULTS: Mincle was increased in the lung tissues of AE-IPF patients compared with those with stable IPF (P = 0.04) and healthy controls (P = 0.009). The survival rate of the Mincle-/-+BLM+HSV group was higher than that of the WT+BLM+HSV group. The mice in the Mincle-/-+BLM+HSV group exhibited milder inflammation and lower acute lung injury scores (P = 0.008). Mincle was expressed on inflammatory monocytes and neutrophils (CD11b+Gr1 +F4/80-) and monocyte-derived macrophages (Mo-AMs, CD11b+Gr1 +F4/80 +) in the BALF of AE-IPF mice. Mo-AMs were significantly increased in the WT+BLM+HSV group compared with the WT+BLM+PBS (P < 0.0001) and Mincle-/-+BLM+HSV (P = 0.0009) groups. Deletion of Mincle decreased the proportion of Th17 cells and Mo-AMs in the Mincle-/-+BLM+HSV group. CONCLUSIONS: Mincle contributed to acute inflammation in AE-IPF by promoting Th17 differentiation.


Assuntos
Fibrose Pulmonar Idiopática , Interleucina-17 , Animais , Camundongos , Camundongos Endogâmicos C57BL , Inflamação , Macrófagos , Bleomicina
2.
Front Immunol ; 11: 977, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32508842

RESUMO

Objective: To investigate the relationship of interleukin (IL)-35 with sarcoidosis. Methods: We enrolled 114 inpatients and outpatients with sarcoidosis at the Shanghai Pulmonary Hospital, and 24 healthy controls between March 2015 and December 2017. Serum and whole blood were collected during the follow-up period. Serum IL-35 levels were detected by ELISA. Proportions of Breg, Tfh, and Treg cells in the peripheral blood were detected using flow cytometry (FCM). The mRNA levels of p35, EBI3, and GAPDH in CD19+ cells and CD4+ cells were detected by real-time PCR. Sarcoidosis granuloma mice models were established with Propionibacterium acnes (PA) and one group was treated with IL-35 antibodies. Proportions of Breg, Tfh, and Treg cells in the peripheral blood and bronchoalveolar lavage fluid (BALF) were detected by FCM. Results: The IL-35 levels and the proportions of Breg and Tfh cells in the peripheral blood of patients with active sarcoidosis were significantly higher compared to patients with stable sarcoidosis and healthy controls. Moreover, the IL-35 level in patients with progressive disease was lower than that found at the initial visit. EBI3 and p35 mRNA levels in CD19+ cells for patients with active sarcoidosis were significantly higher as compared to patients with stable sarcoidosis and healthy controls, while there were no significant differences in p35 and EBI3 mRNA levels in CD4+ cells between the three groups. In the mouse model of sarcoidosis, there were loose granulomata (macrophage accumulation in the bronchial areas and immature granuloma) after intervention with IL-35 antibodies. Meanwhile, the proportions of Breg cells in the peripheral blood and BALF of the model were significantly increased, while the proportion of Treg cells declined significantly. After intervention with IL-35 antibodies, the proportion of Breg cells in the peripheral blood of mice decreased significantly as compared to the mice not exposed to anti-IL-35 antibodies. Conclusion: IL-35 levels increased significantly in the serum of patients with active sarcoidosis, and lower IL-35 levels were correlated with persistent disease. Serum IL-35 levels might be better correlated with Breg cell functions.


Assuntos
Interleucinas/sangue , Sarcoidose/imunologia , Adulto , Animais , Anticorpos/uso terapêutico , Linfócitos B Reguladores/imunologia , Estudos de Casos e Controles , Modelos Animais de Doenças , Progressão da Doença , Feminino , Granuloma , Humanos , Interleucinas/imunologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Pessoa de Meia-Idade , Sarcoidose/sangue , Organismos Livres de Patógenos Específicos , Linfócitos T Reguladores/imunologia
3.
Chem Commun (Camb) ; 55(84): 12627-12630, 2019 Oct 17.
Artigo em Inglês | MEDLINE | ID: mdl-31580342

RESUMO

A porous NiFe (oxy)hydroxide catalyst fabricated on n+pp+-Si/Ni/NiOx, which is converted from an electrodeposited NiFe oxysulfide, allows a silicon photoanode for water splitting to hit a record 5.1% efficiency with good stability of up to 135 h under 40 mA cm-2 in 1.0 M NaOH.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA